Form fit function.png
Conformis Reports First Quarter 2021 Financial Results
May 05, 2021 16:05 ET | Conformis, Inc.
BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
lumos.png
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
May 05, 2021 16:01 ET | Lumos Pharma, Inc.
Newly released PK/PD data from prior study in PGHD support endogenous LUM-201 MOA and use of Predictive Enrichment Markers (PEMs) to identify patients likely to respond to LUM-201 Data presented...
Bio-Sig-Logo-horiz.jpg
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
May 04, 2021 09:15 ET | BioSig Technologies, Inc.
Westport, CT, May 04, 2021 (GLOBE NEWSWIRE) -- The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians...
myriad logo.jpg
Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
May 03, 2021 16:05 ET | Myriad Genetics, Inc.
Highlights: Revenue of $173.1 million increases 12% sequentiallyGAAP earnings per share of ($0.52), adjusted EPS of ($0.06) improves $0.06 sequentiallyTotal test volumes increase 5% sequentially...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. Invited to Present at Wall Street Conference
May 03, 2021 12:00 ET | BioSig Technologies, Inc.
Westport, CT, May 03, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
lumos.png
Lumos Pharma to Report First Quarter 2021 Financial Results and Host Conference Call on May 5, 2021
April 28, 2021 09:00 ET | Lumos Pharma, Inc.
AUSTIN, Texas, April 28, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced it will...
Bio-Sig-Logo-horiz.jpg
BioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona
April 27, 2021 09:30 ET | BioSig Technologies, Inc.
Westport, CT, April 27, 2021 (GLOBE NEWSWIRE) -- The clinic is conducting an evaluation of the PURE EP(tm) System, a signal processing technology for cardiac arrhythmia treatmentsNew installation...
lumos.png
Newly Released Data on Three PGHD Patients Treated with LUM-201 in Prior Phase 2 Study To Be Presented in Lumos Pharma Key Opinion Leader Webinar
April 27, 2021 08:00 ET | Lumos Pharma, Inc.
AUSTIN, Texas, April 27, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced that new...
Rackspace_Technology_Logo_RGB_BLK.jpg
Apria Healthcare Collaborates with Rackspace Technology to Leave the Data Center Resulting in Improved Customer Experience and Increased Savings
April 22, 2021 10:53 ET | Rackspace Technology, Inc.
SAN ANTONIO, April 22, 2021 (GLOBE NEWSWIRE) -- Rackspace Technology (NASDAQ: RXT), an end-to-end multicloud technology solutions company, today announced a collaboration with Apria Healthcare, a...
ibn-iw-globe-2.png
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Mel Engle, CEO of Predictive Oncology Inc.
April 21, 2021 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, April 21, 2021 (GLOBE NEWSWIRE) -- (via InvestorWire) InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...